Floatz logo

FLUOROURACILUM

Diabetes

Haibo ShaoSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

35 Active assets in the Diabetes cohort.

Asset / SponsorPhaseRating
Humulin R
Mostafa Bahaa
Phase 4BBB
Semaglutide
LMC Diabetes & Endocrinology Ltd.
Phase 4BB
Liraglutide
University of Leicester
Phase 4BB
Ezetimibe
University of Oxford
Phase 4BB
Dapagliflozin
Erbil Polytechnic University
Phase 4BB

View all 50 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →